Master in Regulation and Evaluation of Medicines and Health Products

Aims

The Master’s study cycle in Regulation and Evaluation of Medicines and Health Products lasts 2 academic years, organized into 4 semesters, and aims to train specialists in the regulatory affairs of medicines (“Regulatory Affairs”) integrated with the scientific components of its life cycle.

This course aims to increase de knowledge on all the regulatory aspects, laws and directives, science based approaches on the Marketing authorisation in European Union for Medicinal Human Medicines and Veterinary Medicines. Furthermore, this course will include legislation in Health Products based on Medicinal Plants, Medical Devices as well as patent laws, price regulation and others.

This course will also guarantee the training of professionals that can work and solve complex issues in regulatory affairs and can contribute to optimize decision making process.

Teaching Language

The classes are per default lectured in Portuguese unless non-Portuguese speaking applicant is admitted. If a non-Portuguese speaking applicant is admitted, the great majority of lectures will be spoken in English. The large majority course contents and materials are written in English.

Study plan

ECTS
120 ECTS:
60 – correspond to the first two semesters.
60 – correspond to the Dissertation.

Duration
2 academic years / 4 semesters

Regime
After-work

Accreditation

Study cycle accredited by the Higher Education Assessment and Accreditation Agency (A3ES) on 06/10/2023, under code ACEF/2122/0517907, for a period of 6 years from 31/07/2022.

 

Career Opportunities

The course trains specialists in Regulatory Science, conferring general and specific knowledge about the studies that are part of the drug development from small molecules to biotechnological drugs or gene or cellular basis, in the perspective of technical-scientific and regulatory requirements in terms of studies and methodologies.

These specialists will have competencies to carry out professional activities in Regulatory Drug Agencies, in Research and Regulation Departments of Pharmaceutical Industries, as well as in the Research Institute of Medicine and in the Academy.

Schedule

Classes will be held on Thursday from 6:30 p.m to 9:30 p.m, on Fridays from 6:00 p.m. to 9:30 p.m., and on Saturdays from 9:00 p.m. to 5:30 p.m. During the period of evaluations the schedule is set.

The classes will take place at the Faculty of Pharmacy of the University of Lisbon.

2023/2024

Fees and Tuition

Full-time general student

National Students

Annual fee: 4.500,00 € (1st year) | 1.000,00 € (2nd year)

International students
Annual fee: 4.500,00 € (1st year) | 1.000,00 € (2nd year)

Consult associated documentation

Contact

Postgraduate Studies Office: mestrados@ff.ulisboa.pt

Share